Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 – Exclusive Report by MarketsandMarkets™

The report 'Elastomeric Infusion Pumps Marketby Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region – Global Forecast to 2030', elastomeric infusion pumps is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% […]

Hut 8 Reports Third Quarter 2025 Results

1.5GW+ expansion program accelerates development flywheel, underscores commercial velocity, and supports long runway for growth Earnings Release Highlights — Revenue of $83.5 million, net income of $50.6 million, and Adjusted EBITDA of $109.0 million. — Total Energy Capacity Under Management1of 1,020 megawatts (MW) as of September 30, 2025. — Development pipeline of 8,650 MW as

MPLX LP Reports Third-Quarter 2025 Financial Results; Announces Increase to Quarterly Distribution of 12.5%

— Increased quarterly distribution 12.5% for the second consecutive year, to $4.31 per unit annualized — Third-quarter net income attributable to MPLX of $1.5 billion and net cash provided by operating activities of $1.4 billion — Adjusted EBITDA attributable to MPLX of $1.8 billion, reflecting execution of strategic priorities — Distributable cash flow of $1.5

Marathon Petroleum Corp. Reports Third-Quarter 2025 Results

— Third-quarter net income attributable to MPC of $1.4 billion, or $4.51 per diluted share, adjusted net income of $915 million, or $3.01 per diluted share — $3.2 billion of adjusted EBITDA, driven by strong Refining & Marketing execution; and continued Midstream growth — $926 million of capital returned, inclusive of $650 million of share

Nonprofit Adoption of Path2Response Audiences Validates Demand for Donation-Based Audiences

Broomfield, CO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Path2Response, a leading provider of retail purchase and donation-based digital audiences, today announced significant momentum within the nonprofit sector. The company reports rapidly growing usage across its 19 distinct donor-by-cause categories, demonstrating the effectiveness of these audiences in helping charitable organizations identify and acquire high-value, new-to-file donors.

Planet 13 Announces Release Date of Third Quarter 2025 Financial Results

(CNSX:PLTH),(OTC US:PLNH),(Other OTC:PLNH),(CNSX:PLTH.CN), LAS VEGAS, Nov. 04, 2025 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company“), a leading vertically-integrated multi-state cannabis company, announced today that it plans to release its financial results for the third quarter ended September 30th, 2025, on November 12th, 2025, aftermarket. Planet 13

Apollo Reports Third Quarter 2025 Results

(NYSE:APO), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) today reported results for the third quarter ended September 30, 2025. Marc Rowan, Chairman and Chief Executive Officer at Apollo said, “Our outstanding third quarter results reflect broad based momentum across the business. In

Pet Valu Reports Third Quarter 2025 Results

(TSX:PET), MARKHAM, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, today announced its financial results for the third quarter ended September 27, 2025. Third Quarter Highlights System-wide sales(1) were $373.9 million, an increase of

Kura Oncology Reports Third Quarter 2025 Financial Results

Kura Oncology Reports Third Quarter 2025 Financial Results GlobeNewswire November 04, 2025 – New Drug Application for ziftomenib in adults with R/R NPM1-m AML remains under FDA Priority Review, with a PDUFA target action date of November 30, 2025 – – KOMET 017 Phase 3 trials to evaluate ziftomenib in combination with intensive and non-intensive

eGain to Announce Fiscal 2026 First Quarter Financial Results on November 12, 2025

(NASDAQ:EGAN), SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the AI knowledge platform for service, will announce its fiscal 2026 first quarter financial results after the close of regular market trading on Wednesday, November 12, 2025, followed by an investor conference call and webcast at 2:00 p.m. Pacific Time (5:00 p.m. ET).

Scroll to Top